Microsoft is up 12% since my last update, and is now over priced on an EC of 70, against fair value of 55. Unless I am missing something, the stock needs to consolidate it's powerful advance before considering going higher as it is not healthy for a stock to keep becoming more expensive. Maybe it's the 2.1% dividend yield that's attracting investors? But on an EC of 70 it is a little expensive for my taste. Not a good buy at current levels so the Buy % is 35%.

Downside during any correction appears limited to $230. Below which are a series of previous highs from 224 to 227. So there is heavy support under Microsoft. It's difficult to see Microsoft trading much lower than that. Therefore a probable buying level for MSFT is $230.

TOP AI Mega-trend Stocks Analysis

The rest of this extensive analysis that concludes in buying levels for AI tech stocks. AI Stock Buying Levels, Ratings, Valuations and Trend Analysis into Market Correction has first been made available to Patrons who support my work.

Contents:

TESLA
Cathy Wood ARK Funds CRASH!
India Apocalypse Heralds Catastrophe for Pakistan and Bangladesh
Covid-19 in Italy in August 2019!
Stock Market Early Summer Correction Trend Forecast
Stocks Expensive or Cheap Indicator (EC)
AI Stock Buy % Rating Review
1. GOOGLE - $2398
2. AMAZON - $3312
3. MICROSOFT - $252.5
4. APPLE - $130
5. FACEBOOK - $320
6. NVIDIA - $592.5
7. AMD - $78.8
11. IBM - $145.5
12. INTEL - $57.7
AI Stocks Buying Levels Update May 2021
So what am I going to do
GPU Mining FREE MONEY!
CHIA Crypto Farming with Your Hard Drives Insanity!

So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

Including my most recent analysis: Five More Small Cap Bio and Tech Stocks to Invest for 2021 and Beyond!

Invest and Forget
Stock Market Early Summer Correction Review
AI Stocks Strength vs Weakness
RAMPANT MONEY PRINTING INFLATION BIG PICTURE!
HIGH RISK STOCK BUYING LEVELS
RISK RATINGS
WESTERN DIGITAL - WDC $71 - CHIA! - Risk 1
Life Sciences Biotech Smaller Cap High Risk Stocks Investing Binge
Biotech stock 1 - Cheap Low Risk Pharma - Risk 1
Biotech stock 2 - HIGH RISK GENE EDITING - Risk 9
Biotech stock 3 - Low Risk 2
Biotech stock 4 - X10 for Max Risk 10
High Risk Stocks Portfolio Buying Levels
Covid India Black Mold Epidemic
Bitcoin and Raven Coin Buying Levels

My analysis schedule includes:

Bitcoin Trend Forecast - 50% done
More X10 Biotech Tech Stocks - 40% done
UK House Prices Trend Analysis - 10% done
How to Get Rich! - 70% done
US Dollar and British Pound analysis
Gold and SIlver Price Analysis

Again for immediate access to all my work do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

And ensure you are subscribed to my ALWAYS FREE newsletter for my next in-depth analysis.

Your analyst locked an loaded for the next AI stocks discount sale that should soon start to materialise as per my forecast of 11th Feb..

Nadeem Walayat

http://www.marketoracle.co.uk

Nadeem Walayat has over 30 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.

Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.

Nadeem Walayat Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.